Shandong Sino Pharmaceutical Technology

Shandong Sino Pharmaceutical Technology is a high-tech pharmaceutical research and development enterprise headquartered in Jinan, China. Established in 2008, the company specializes in the development of high-end generic drugs and the innovation of small molecule therapeutics. It offers a full spectrum of services including drug discovery, process chemistry, formulation development, and clinical trial management, operating as both a CRO and CDMO. The company has a strong track record in drug consistency evaluation and regulatory filings within the Chinese pharmaceutical landscape. Their therapeutic focus primarily includes cardiovascular diseases, oncology, and metabolic disorders.